Acadia Pharmaceuticals buy Citigroup Inc.
Start price
07.08.25
/
50%
€20.40
Target price
07.08.26
-
Performance (%)
23.19%
End price
08.08.26
€25.13
Summary
This prediction ended on 08.08.26 with a price of €25.13. The BUY prediction by Citigroup_Inc_ finished with a performance of 23.19%. Citigroup_Inc_ has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 2.526% | 2.526% | 17.294% |
| iShares Core DAX® | 0.625% | 4.952% | 8.658% |
| iShares Nasdaq 100 | 1.160% | -1.160% | 26.817% |
| iShares Nikkei 225® | 2.356% | -1.354% | 48.195% |
| iShares S&P 500 | 0.631% | 1.380% | 22.985% |
Comments by Citigroup_Inc_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.83
08.05.26
08.05.26
€27.29
08.05.27
08.05.27
34.56%
12.08.26
12.08.26
Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.06
08.08.25
08.08.25
43.94%
09.08.25
09.08.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€27.83
09.05.25
09.05.25
8.26%
10.05.25
10.05.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
13.12.23
13.12.23
€35.17
13.12.24
13.12.24
-17.60%
14.12.24
14.12.24